Cigna (NYSE:CI) reported quarterly earnings of $6.22 per share which beat the analyst consensus estimate of $5.48 by 13.5 percent. This is a 18.7 percent increase over earnings of $5.24 per share from the same period last year. The company reported quarterly sales of $45.50 billion which beat the analyst consensus estimate of $44.41 billion by 2.45 percent. This is a 5.55 percent increase over sales of $43.11 billion the same period last year.
Sorrento Reports Results With mRNA Vaccine For COVID-19 Delivered With The MuVaxx Lymphatic Drug Delivery Device
Sorrento's mRNA vaccine ("STI-mRNA") delivered with the MuVaxx™ Lymphatic Drug Delivery Device ("MuVaxx"), at 1/10th of the dose vs an LNP-mRNA reference
